The Efficiency of Resveratrol on Adenomatous Polyposis Coli Gene in Mice Colorectal Cancer Treated with Azoxymethane
DOI:
https://doi.org/10.61841/nv6a2772Keywords:
Azoxymethane, Efficiency of Resveratrol, Polyposis ColiAbstract
Colorectal cancer (CRC) is the third most common cancer and the fourth most common cause of cancer-related death. Most cases of CRC are detected in Western countries, with its incidence increasing year by year. The probability of suffering from colorectal cancer is about 4%–5% and the risk for developing CRC is associated with personal features or habits such as age, chronic disease history and lifestyle. 5-Fluorouracil (5-FU) is the most commonly used therapy and the conventional treatment for colorectal cancer. However, its toxicity to normal tissues is considered a major obstacle to successful cancer chemotherapy; thus, resveratrol is used in combination with 5-FU to reduce its toxicity. The goal of our study is to investigate the mechanisms underlying the effects of resveratrol alone and in combination with 5-FU in inhibiting experimentally induced colon cancer. Gene expression analysis showed seemed lower expression of APC (adenomatus polyposis coli) gene in ( +) control significantly difference between positive and negative control by given Azoxymethane and normal saline respectively, The mean expression levels of (-) control (n=6) and combination (Res. +5-FU) (n=6) mice in the colon, There are high statistically significant expression differences. Error bars represent the 95% confidence intervals.
Downloads
References
Matsuzaki, Y., Umemoto, T., Tanaka, Y., Okano, T., Yamato, M. (2015). β2-Microglobulin is an
appropriate reference gene for RT-PCR-based gene expression analysis of hematopoietic stem cells.
Regenerative Therapy, 1, pp. 91-97.
Tian 1, Zhi-You Zhou, Shi-Gang Sun, Yong Ding, Zhong Lin Wang Synthesis of Tetrahexahedral Platinum
Nanocrystals With High-Index Facets and High Electro-Oxidation Activity 2007Affiliations expand
PMID: 17478717.
Hsieh, P. & Yamane, K., (2008). DNA mismatch repair: molecular mechanism, cancer, and ageing.
Mechanisms of Ageing and Development. 129, 391-407.
Huda Hameed Kadhim Alabbody and Inam Jasim Lafta (2019): Incidence of Canine Digestive System
Tumours in Baghdad Province. The Iraqi Journal of Veterinary Medicine, 43 (2): 67 – 76.
Daniel B Longley 1, D Paul Harkin, Patrick G Johnston 5-fluorouracil: Mechanisms of Action and Clinical
Strategies 2003.
Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P, Jandik P, Ivenson T,
Carmichael J, Alakl M, Gruia G, Awad L, Rougier PIrinotecan combined with fluorouracil compared with
fluorouracil alone as first-line treatment for metastatic colorectal cancer. Lancet 355: 1041-1047.
Giacchetti 1, B Perpoint, R Zidani, N Le Bail, R Faggiuolo, C Focan, P Chollet, J F Llory, Y Letourneau, B
Coudert, F Bertheaut-Cvitkovic, D Larregain-Fournier, A Le Rol, S Walter, R Adam, J L Misset, F
Lévi2000 Phase III Multicenter Randomized Trial of Oxaliplatin Added to Chronomodulated Fluorouracil
Leucovorin as First-Line Treatment of Metastatic Colorectal Cancer Jan;18(1):136-47.
Noordhuis 1, U Holwerda, C L Van der Wilt, C J Van Groeningen, K Smid, S Meijer, H M Pinedo, G J
Peters 2004.5-Fluorouracil Incorporation Into RNA and DNA in Relation to Thymidylate Synthase
Inhibition of Human Colorectal Cancers Jul;15(7):1025-32.
Grem JL. 5-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.
Invest New Drugs 2000; 18: 299–313.
Saud, S.M., Li, W., Morris, N.L., Matter, M.S., Colburn, N.H., Kim, Y.S., Young, M.R., (2014).
Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by
suppressing oncogenic Kras expression. Carcinogenesis. 35, 2778-2786.
Hung, K.E., Maricevich, M.A., Richard, L.G., Chen, W.Y., Richardson, M.P., Kunin, A., Bronson, R.T.,
Mahmood, U., Kucherlapati, R., (2010). Development of a mouse model for sporadic and metastatic colon
tumors and its use in assessing drug treatment. Proceedings of the National Academy of Sciences of the
United States of America. 107, 1565-1570.
Aoki, K. & Taketo, M.M., (2007). Adenomatous polyposis coli (APC): a multi-functional tumor suppressor
gene. Journal of Cell Science. 120, 3327-3335.
Hasanpour, M., Galehdari, H., Masjedizadeh, A., Ajami, N., (2014). A unique profile of adenomatous
polyposis coli gene mutations in Iranian patients suffering sporadic colorectal cancer. Cell Journal. 16, 17
24.
Storniolo, C.E. & Moreno, J.J., (2012). Resveratrol metabolites have an antiproliferative effect on intestinal
epithelial cancer cells. Food Chemistry. 134, 1385-1391.
Mishra, R.N., (2011). Resveratrol -The New Rasayan (Antiaging) Drug. Current Research in Medicine and
Medical Sciences. 1, 5-18.
Steward, W.P. & Brown, K., (2013). Cancer chemoprevention: a rapidly evolving field. British Journal of
Cancer. 109, 1-7.
Rasool, S., Rasool, V., Naqvi, T., Ganai, B.A., Shah, B.A., (2014). Genetic unraveling of colorectal cancer.
Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine.
Dušek L., Mužík J., Malúšková, D., Šnajdrová L., (2015). Epidemiology of colorectal cancer: international
comparison [online]. Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University,
Brno (Czech Republic). Available from http://www.crcprevention.eu/index.php?pg=colorectal-cancer
epidemiology
Lee, S.Y., Haq, F., Kim, D., Jun, C., Jo, H.J., Ahn, S.M., Lee, W.S., (2014). Comparative genomic analysis
of primary and synchronous metastatic colorectal cancers. PloS One. 9, e90459.
Clancy, S., (2008). DNA damage & repair: mechanisms for maintaining DNA integrity. Nature Education
1(1):103
Hanahan, D. & Weinberg, R.A., (2011). Hallmarks of cancer: the next generation. Cell.144, 646-674.
Sato, T. &Clevers, H., (2013). Growing self-organizing mini-guts from a single intestinal stem cell:
mechanism and applications. Science (New York, N.Y.). 340, 1190-1194.
Wu, X.S., Xi, H.Q., Chen, L., (2012). Lgr5 is a potential marker of colorectal carcinoma stem cells that
correlates with patient survival. World Journal of Surgical Oncology. 10, 244-7819-10-244.
Chung Yu, Ping Kwan, Stanley K.K. Cheung, Amy Ho,4 and Larry Baum. 2018. Effects of Resveratrol and
Morin on Insoluble Tau in Tau Transgenic Mice Nov 9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
